Registered entities
EsoBiotec
Reg. No. 0756.885.159Belgium
Innovation
1 patent family — focus: Chemistry & metallurgy; filing pace active.
Developer of in vivo adoptive cell therapies for cancer and autoimmune diseases. This involves engineering immune cells directly within the patient's body, eliminating the need for complex ex vivo manufacturing and reduc
1 patent family — focus: Chemistry & metallurgy; filing pace active.